[Other] Safety and efficacy of continuous subcutaneous levodopa每carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial |
Reward10points
|